Literature DB >> 2500486

Rapid isolation of Tamm-Horsfall glycoprotein (uromodulin) from human urine.

F Serafini-Cessi1, G Bellabarba, N Malagolini, F Dall'Olio.   

Abstract

An isolation method for Tamm-Horsfall protein is described which is based on the observation that a diatomaceous earth filter is able to retain most of the glycoprotein present in urine and that the glycoprotein is easily desorbed from the filter by deionized water. This behaviour depends on the tendency of Tamm-Horsfall glycoprotein at normal urinary concentrations to form a gel in a solution containing mono- and divalent ions. By means of two-step filtration, the glycoprotein was purified to homogeneity. The yield was of about 20 mg/l of urine, and the time required for the isolation was approximately 5-6 h. This procedure should be particularly useful for preparing large amounts of Tamm-Horsfall glycoprotein oligosaccharides in order to investigate their potential use as immunosuppressive agents both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500486     DOI: 10.1016/0022-1759(89)90241-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  An evaluation of Tamm-Horsfall protein glycans in kidney stone formers using novel techniques.

Authors:  Sulabha Argade; Tony Chen; Timothy Shaw; Zoltan Berecz; William Shi; Biswa Choudhury; C Lowell Parsons; Roger L Sur
Journal:  Urolithiasis       Date:  2015-05-03       Impact factor: 3.436

2.  Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein.

Authors:  Pragasam Viswanathan; Jeffrey D Rimer; Ann M Kolbach; Michael D Ward; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urol Res       Date:  2011-01-13

3.  Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.

Authors:  Marcus D Säemann; Thomas Weichhart; Maximilian Zeyda; Günther Staffler; Michael Schunn; Karl M Stuhlmeier; Yuri Sobanov; Thomas M Stulnig; Shizuo Akira; Alexander von Gabain; Uwe von Ahsen; Walter H Hörl; Gerhard J Zlabinger
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  The sugar moiety of Tamm-Horsfall protein is affected by the carbohydrate-deficient glycoprotein type I syndrome. A case study.

Authors:  T Olczak; M Olczak; A Kubicz
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

5.  The patterns of the complex- and oligomannose-type glycans of uromodulin (Tamm-Horsfall glycoprotein) in the course of pregnancy.

Authors:  J J Van Rooijen; P Hermentin; J P Kamerling; J F Vliegenthart
Journal:  Glycoconj J       Date:  2001-07       Impact factor: 2.916

6.  Clinically Viable Assay for Monitoring Uromodulin Glycosylation.

Authors:  Milani Wijeweera Patabandige; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2020-12-10       Impact factor: 3.109

Review 7.  N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases.

Authors:  Franca Serafini-Cessi; Angela Monti; Daniela Cavallone
Journal:  Glycoconj J       Date:  2005-11       Impact factor: 3.009

8.  The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae.

Authors:  Su Yu; Anson W Lowe
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

9.  A structured interdomain linker directs self-polymerization of human uromodulin.

Authors:  Marcel Bokhove; Kaoru Nishimura; Martina Brunati; Ling Han; Daniele de Sanctis; Luca Rampoldi; Luca Jovine
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

10.  Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH.

Authors:  Alena Stsiapanava; Chenrui Xu; Shunsuke Nishio; Ling Han; Nao Yamakawa; Marta Carroni; Kathryn Tunyasuvunakool; John Jumper; Daniele de Sanctis; Bin Wu; Luca Jovine
Journal:  Nat Struct Mol Biol       Date:  2022-03-10       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.